Career records & work history
Medicine Doctors
Shuang Chen
Specialties:
Neurology
Education:
Beijing School Of Medicine (1993)
Shuang Chen, 433206 S Lituanica Ave, Chicago, IL 60608
Shuang Chen Phones & Addresses
Chicago, IL
Kenosha, WI
Kettering, OH
Mentions for Shuang Chen
Shuang Chen resumes & CV records
Resumes
Senior Regulatory Compliance Specialist Ii
Location:
16616 Benton Taylor Dr, Chesterfield, MO 63005
Industry:
Environmental Services
Work:
Penn State University
Oct 1, 2011 - Oct 31, 2013
Postdoctoral Associate Acs Engineering Oct 1, 2011 - Oct 31, 2013
Senior Regulatory Compliance Specialist Ii Penn State University Jan 2008 - Aug 2011
Research Assistant Penn State University Aug 2007 - Dec 2007
Teaching Assistant Penn State University Jun 2007 - Aug 2007
Mentor Penn State University Jun 2006 - Aug 2007
Volunteer Research Assistant Beijing Normal University Jul 2003 - May 2005
Research Assistant Beijing Education Press 2004 - 2005
Part-Time Editor
Postdoctoral Associate Acs Engineering Oct 1, 2011 - Oct 31, 2013
Senior Regulatory Compliance Specialist Ii Penn State University Jan 2008 - Aug 2011
Research Assistant Penn State University Aug 2007 - Dec 2007
Teaching Assistant Penn State University Jun 2007 - Aug 2007
Mentor Penn State University Jun 2006 - Aug 2007
Volunteer Research Assistant Beijing Normal University Jul 2003 - May 2005
Research Assistant Beijing Education Press 2004 - 2005
Part-Time Editor
Education:
Penn State University 2008 - 2011
Doctorates, Doctor of Philosophy, Meteorology, Philosophy Penn State University 2007 - 2008
Master of Science, Masters, Meteorology Beijing Normal University 2003 - 2005
Master of Science, Masters, Chemistry Beijing Normal University 1999 - 2003
Bachelors, Bachelor of Science, Chemistry Putian No.1 Middle School
Pennsylvania State University
Doctorates, Doctor of Philosophy, Meteorology Pennsylvania State University
Master of Science, Masters, Meteorology
Doctorates, Doctor of Philosophy, Meteorology, Philosophy Penn State University 2007 - 2008
Master of Science, Masters, Meteorology Beijing Normal University 2003 - 2005
Master of Science, Masters, Chemistry Beijing Normal University 1999 - 2003
Bachelors, Bachelor of Science, Chemistry Putian No.1 Middle School
Pennsylvania State University
Doctorates, Doctor of Philosophy, Meteorology Pennsylvania State University
Master of Science, Masters, Meteorology
Skills:
Science, Matlab, Meteorology, Data Analysis, Environmental Awareness, Aermod, Chemistry, Environmental Compliance, Air Permitting, Air Dispersion Modeling, Calpuff, Nsps, Neshap, Nerc, Risk Management Plans, Process Safety Management, Atmospheric Chemistry, Programming, Microsoft Office, Sensitivity Analysis, Monte Carlo Simulation, Technical Presentations, Facsimile, Explorehd, Proposal Writing, Technical Writing, Statistics, Ion Chromatography, Problem Solving, Public Speaking, Model Evaluation, Research, Teamwork, Outlook, Endnote, Unix, Mac Os X, Air Pollution, Environmental Science, Data Management, Highly Motivated Self Starter, Multi Tasking, Bilingual, Atmospheric Science
Interests:
Children
Environment
Environment
Languages:
English
Mandarin
Mandarin
Certifications:
Aermod Air Dispersion Modeling
Calpuff Air Dispersion Modeling
Air Permitting 101
Calpuff Air Dispersion Modeling
Air Permitting 101
Senior Principal Research Scientist
Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Abbvie
Senior Principal Research Scientist Abbvie Sep 2017 - Aug 2019
Principal Research Scientist The Janssen Pharmaceutical Companies of Johnson & Johnson Sep 2016 - Aug 2017
Associate Director Abbvie Nov 2013 - Aug 2016
Senior Scientist Iii Abbvie Jan 2013 - Oct 2013
Senior Scientist Ii Abbott Jan 2009 - Dec 2012
Associate Research Investigator and Senior Scientist Ii Abbott May 2006 - Dec 2008
Senior Research Chemist University of Wisconsin-Madison Dec 2004 - Apr 2006
Postdoctoral Research Associate
Senior Principal Research Scientist Abbvie Sep 2017 - Aug 2019
Principal Research Scientist The Janssen Pharmaceutical Companies of Johnson & Johnson Sep 2016 - Aug 2017
Associate Director Abbvie Nov 2013 - Aug 2016
Senior Scientist Iii Abbvie Jan 2013 - Oct 2013
Senior Scientist Ii Abbott Jan 2009 - Dec 2012
Associate Research Investigator and Senior Scientist Ii Abbott May 2006 - Dec 2008
Senior Research Chemist University of Wisconsin-Madison Dec 2004 - Apr 2006
Postdoctoral Research Associate
Education:
University of Wisconsin - Madison 2004 - 2006
The University of British Columbia 1999 - 2004
Doctorates, Doctor of Philosophy, Chemistry
The University of British Columbia 1999 - 2004
Doctorates, Doctor of Philosophy, Chemistry
Skills:
Analytical Chemistry, Drug Development, Hplc, Formulation, Drug Delivery, Gmp, Solid State, Crystallization, Drug Discovery, Flexibility, Teamwork, Innovation, Communication
Languages:
English
Mandarin
Mandarin
Registered Nurse
Work:
Registered Nurse
Shuang Chen
Shuang Chen
Shuang Chen
Publications & IP owners
Us Patents
Crystalline Forms Of Rapamycin Analogs
US Patent:
7812032, Oct 12, 2010
Filed:
Jul 23, 2007
Appl. No.:
11/781804
Inventors:
Shekhar Viswanath - Vernon Hills IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D 498/18
A61K 31/395
A61K 31/395
US Classification:
514291, 540456
Abstract:
A rapamycin analog composition includes a crystalline form of a rapamycin analog. The crystal can be a hydrate, dehydrate, solvate, or desolvate. The rapamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof:.
Methods Of Manufacturing Crystalline Forms Of Rapamycin Analogs
US Patent:
7820812, Oct 26, 2010
Filed:
Jul 23, 2007
Appl. No.:
11/781807
Inventors:
Shekhar Viswanath - Vernon Hills IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D 498/18
US Classification:
540456
Abstract:
A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split.
Crystalline Forms Of Rapamycin Analogs
US Patent:
8030326, Oct 4, 2011
Filed:
Sep 20, 2010
Appl. No.:
12/886410
Inventors:
Shekhar Viswanath - Vernon Hills IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine IL, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine IL, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/395
A61P 37/06
A61P 37/06
US Classification:
514291
Abstract:
Provided is a rapamycin analog composition including a crystalline form of a rapamycin analog. The crystal can be a hydrate. dehydrate, solvate, or desolvate. The rampamycin analog can have a structure of Formula 1, which is optionally a prodrug, salt, derivative, or combination thereof:.
Methods Of Manufacturing Crystalline Forms Of Rapamycin Analogs
US Patent:
8034926, Oct 11, 2011
Filed:
Sep 20, 2010
Appl. No.:
12/886398
Inventors:
Shekhar Viswanath - Vernon Hills IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Larry Bartelt - Highland Park IL, US
Robert Leanna - Grayslake IL, US
Michael Rasmussen - Racine WI, US
Madhup Dhaon - Mundelein IL, US
Rodger Henry - Wildwood IL, US
Thomas Borchardt - Kenosha WI, US
Shuang Chen - Gurnee IL, US
Geoff Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D 498/18
US Classification:
540456
Abstract:
A process for preparing a crystalline rapamycin analog includes: combining the rapamycin analog with an organic medium to form a mixture; incubating the mixture until the rapamycin analog crystallizes; and recovering the crystalline rapamycin analog. The organic medium can be a solvent, and the process can include causing the rapamycin analog to dissolve into the solvent, and incubating the solvent until the rapamycin analog crystallizes. The following can also be performed: forming a slurry of crystalline rapamycin analog; stirring the rapamycin analog mixture until the rapamycin analog crystallizes; saturating the rapamycin analog solution; forming a supersaturated rapamycin analog solution; combining an antisolvent with the rapamycin analog and the solvent to form a biphasic mixture, and incubating the biphasic mixture to cause a liquid-liquid phase split.
Anti-Infective Agents And Uses Thereof
US Patent:
8178548, May 15, 2012
Filed:
Sep 17, 2008
Appl. No.:
12/212315
Inventors:
Pamela L. Donner - Mundelein IL, US
John T. Randolph - Libertyville IL, US
Allan C. Krueger - Gurnee IL, US
David A. Betebenner - Libertyville IL, US
Douglas K. Hutchinson - Antioch IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
John K. Pratt - Kenosha WI, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
John E. Hengeveld - Kenosha WI, US
Rodger F. Henry - Wildwood IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
John T. Randolph - Libertyville IL, US
Allan C. Krueger - Gurnee IL, US
David A. Betebenner - Libertyville IL, US
Douglas K. Hutchinson - Antioch IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
John K. Pratt - Kenosha WI, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
John E. Hengeveld - Kenosha WI, US
Rodger F. Henry - Wildwood IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/505
C07D 239/02
C07D 401/00
C07D 239/02
C07D 401/00
US Classification:
514274, 514269, 514309, 514310
Abstract:
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
Anti-Infective Agents And Uses Thereof
US Patent:
8188104, May 29, 2012
Filed:
Sep 17, 2008
Appl. No.:
12/212323
Inventors:
Douglas K. Hutchinson - Antioch IL, US
David A. Betebenner - Libertyville IL, US
David A. DeGoey - Salem WI, US
Pamela L. Donner - Mundelein IL, US
Warren M. Kati - Gurnee IL, US
Allan C. Krueger - Gurnee IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
Christopher E. Motter - Oak Creek WI, US
John K. Pratt - Kenosha WI, US
John T. Randolph - Libertyville IL, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
David A. Betebenner - Libertyville IL, US
David A. DeGoey - Salem WI, US
Pamela L. Donner - Mundelein IL, US
Warren M. Kati - Gurnee IL, US
Allan C. Krueger - Gurnee IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
Christopher E. Motter - Oak Creek WI, US
John K. Pratt - Kenosha WI, US
John T. Randolph - Libertyville IL, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 31/505
C07D 401/00
C07D 239/02
C07D 401/00
C07D 239/02
US Classification:
514274, 514269, 544309, 544310
Abstract:
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
Azaadamantane Derivatives And Methods Of Use
US Patent:
8314119, Nov 20, 2012
Filed:
Nov 5, 2007
Appl. No.:
11/935157
Inventors:
Michael R. Schrimpf - Grayslake IL, US
Diana L. Nersesian - Gurnee IL, US
Kevin B. Sippy - Antioch IL, US
Jianguo Ji - Libertyville IL, US
Tao Li - Grayslake IL, US
Marc Scanio - Lindenhurst IL, US
Lei Shi - Gurnee IL, US
Chih-Hung Lee - Vernon Hills IL, US
William H. Bunnelle - Mundelein IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Paul J. Brackemeyer - Sterling IL, US
Shuang Chen - Gurnee IL, US
Rodger F. Henry - Wildwood IL, US
Diana L. Nersesian - Gurnee IL, US
Kevin B. Sippy - Antioch IL, US
Jianguo Ji - Libertyville IL, US
Tao Li - Grayslake IL, US
Marc Scanio - Lindenhurst IL, US
Lei Shi - Gurnee IL, US
Chih-Hung Lee - Vernon Hills IL, US
William H. Bunnelle - Mundelein IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Paul J. Brackemeyer - Sterling IL, US
Shuang Chen - Gurnee IL, US
Rodger F. Henry - Wildwood IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 31/439
C07D 221/22
C07D 221/22
US Classification:
514294, 546 97
Abstract:
The invention relates to compounds that are azaadamantane derivatives, particularly ether- or amine-substituted azaadamantane derivatives and salts and prodrugs thereof, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.
Anti-Infective Agents And Uses Thereof
US Patent:
8501238, Aug 6, 2013
Filed:
Apr 20, 2012
Appl. No.:
13/451889
Inventors:
Charles A. Flentge - Salem WI, US
Douglas K. Hutchinson - Antioch IL, US
David A. Betebenner - Libertyville IL, US
David A. DeGoey - Salem WI, US
Pamela L. Donner - Mundelein IL, US
Warren M. Kati - Gurnee IL, US
Allan C. Krueger - Gurnee IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
Christopher E. Motter - Oak Creek WI, US
John K. Pratt - Kenosha WI, US
John T. Randolph - Libertyville IL, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Douglas K. Hutchinson - Antioch IL, US
David A. Betebenner - Libertyville IL, US
David A. DeGoey - Salem WI, US
Pamela L. Donner - Mundelein IL, US
Warren M. Kati - Gurnee IL, US
Allan C. Krueger - Gurnee IL, US
Dachun Liu - Waukegan IL, US
Yaya Liu - Buffalo Grove IL, US
Kenton L. Longenecker - Grayslake IL, US
Clarence J. Maring - Palatine IL, US
Christopher E. Motter - Oak Creek WI, US
John K. Pratt - Kenosha WI, US
John T. Randolph - Libertyville IL, US
Todd W. Rockway - Grayslake IL, US
Kent D. Stewart - Gurnee IL, US
Rolf Wagner - Antioch IL, US
Shuang Chen - Gurnee IL, US
Yi Gao - Vernon Hills IL, US
Xiaochun Lou - Long Grove IL, US
Geoff G. Z. Zhang - Libertyville IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
A61K 9/14
A61K 31/505
C07D 239/02
C07D 401/00
A61K 31/505
C07D 239/02
C07D 401/00
US Classification:
424489, 514274, 514269, 544309, 544310
Abstract:
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.